2020
DOI: 10.1101/2020.01.10.896415
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

An overview of the quality assurance and quality control of magnetic resonance imaging data for the Ontario Neurodegenerative Disease Research Initiative (ONDRI): pipeline development and neuroinformatics

Abstract: Large scale research studies combining magnetic resonance imaging data generated at multiple sites on multiple vendor platforms are becoming more commonplace. The Ontario Neurodegenerative Disease Research Initiative (ONDRI -http://ondri.ca/), a project funded by the Ontario Brain Institute (OBI), is a recently established province-wide natural history study, which has recruited more than 500 participants from neurodegenerative disease groups including amyotrophic lateral sclerosis, fronto-temporal dementia, P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
2

Relationship

4
2

Authors

Journals

citations
Cited by 14 publications
(23 citation statements)
references
References 31 publications
(29 reference statements)
0
23
0
Order By: Relevance
“…We analyzed two large multi-site datasets that were drawn from previous studies 1) the Canadian Biomarker Integration Network in Depression (CAN-BIND) with 308 participants (MacQueen et al 2019;Lam et al 2016), and 2) the Parkinson's disease cohort from the Ontario Neurodegeneration Research Initiative (ONDRI) (Farhan et al 2017;Scott et al 2020), with 140 participants with Parkinson's Disease. Demographic information of the two datasets are shown in Table 1.…”
Section: Datasetsmentioning
confidence: 99%
“…We analyzed two large multi-site datasets that were drawn from previous studies 1) the Canadian Biomarker Integration Network in Depression (CAN-BIND) with 308 participants (MacQueen et al 2019;Lam et al 2016), and 2) the Parkinson's disease cohort from the Ontario Neurodegeneration Research Initiative (ONDRI) (Farhan et al 2017;Scott et al 2020), with 140 participants with Parkinson's Disease. Demographic information of the two datasets are shown in Table 1.…”
Section: Datasetsmentioning
confidence: 99%
“…To account for the more rapid motoric and respiratory decline of individuals with ALS, participants in that cohort completed clinical, neuropsychology, and eye tracking assessments at 6-month intervals. Additional information pertaining to the assessment platforms is provided elsewhere 11,[24][25][26][27][28][29][30][31] .…”
Section: Assessment Platformsmentioning
confidence: 99%
“…All data are stored in Brain-CODE 33 : a secure, centralized neuroinformatics system designed for the collection, storage, federation, sharing, and analysis of different types of data using a diverse set of electronic data capture tools including XNAT, RedCap, and LabKey. Rigorous, assessment-specific data pre-processing and quality control procedures were developed and executed to ensure data were of the highest-possible fidelity [26][27][28][29][30][31] . This included investigation of any missing data and the use of detailed, non-numeric missing codes to indicate broad categories for missing values where they could be determined.…”
Section: Data Management and Quality Controlmentioning
confidence: 99%
See 1 more Smart Citation
“…The Ontario Neurodegenerative Research Initiative (ONDRI) is a multi-site prospective cohort study following patients with neurodegenerative diseases including Alzheimer's disease (AD), mild cognitive impairment (MCI), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and cerebrovascular disease (CVD). Over the course of 3 years, multiple assessment platforms acquired comprehensive data from the 520 patients including: neuroimaging ( 1 3 ), clinical and demographic assessments ( 4 ), neuropsychology ( 5 ), genetic variations ( 6 , 7 ), eye tracking and pupillometry, retinal layer analyses using spectral-domain optical coherence tomography ( 8 ), gait and balance performance ( 9 ), and neuropathology. The multi-modal data collected from ONDRI will be used to explore earlier detection, guide development of novel therapy, and improve patient care.…”
Section: Introductionmentioning
confidence: 99%